Global CD19-targeted CAR-T Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 97

Published Date: 22 Nov 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global CD19-targeted CAR-T Cell Therapy market size was valued at US$ 2847 million in 2023 and is forecast to a readjusted size of USD 7582 million by 2030 with a CAGR of 15.3% during review period.

Chimeric antigen receptor (CAR) T-cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. Currently available CAR-T cell therapy products are divided into CD19 targets and BCMA targets. CD19 is the most common target. CD19 is a protein that is found on the surface of most B - cells, including malignant B - cells in certain types of leukemia and lymphoma.

This report is a detailed and comprehensive analysis for global CD19-targeted CAR-T Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global CD19-targeted CAR-T Cell Therapy market size and forecasts, in consumption value ($ Million), 2019-2030
Global CD19-targeted CAR-T Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global CD19-targeted CAR-T Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global CD19-targeted CAR-T Cell Therapy market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CD19-targeted CAR-T Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CD19-targeted CAR-T Cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead (Yescarta&Tecartus), Novartis (Kymriah), Bristol-Myers Squibb (Breyanzi), FOSUNKite (Yescarta), Shanghai Yaoming Juno (Carteyva), Juventas, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
CD19-targeted CAR-T Cell Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
CD19-targeted CAR-T Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Yescarta
    Kymriah
    Tecartus
    Others

Market segment by Application
    Lymphoma
    Lymphocytic Leukemia

Market segment by players, this report covers
    Gilead (Yescarta&Tecartus)
    Novartis (Kymriah)
    Bristol-Myers Squibb (Breyanzi)
    FOSUNKite (Yescarta)
    Shanghai Yaoming Juno (Carteyva)
    Juventas

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CD19-targeted CAR-T Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CD19-targeted CAR-T Cell Therapy, with revenue, gross margin, and global market share of CD19-targeted CAR-T Cell Therapy from 2019 to 2024.
Chapter 3, the CD19-targeted CAR-T Cell Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CD19-targeted CAR-T Cell Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CD19-targeted CAR-T Cell Therapy.
Chapter 13, to describe CD19-targeted CAR-T Cell Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of CD19-targeted CAR-T Cell Therapy by Type
        1.3.1 Overview: Global CD19-targeted CAR-T Cell Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Type in 2023
        1.3.3 Yescarta
        1.3.4 Kymriah
        1.3.5 Tecartus
        1.3.6 Others
    1.4 Global CD19-targeted CAR-T Cell Therapy Market by Application
        1.4.1 Overview: Global CD19-targeted CAR-T Cell Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Lymphoma
        1.4.3 Lymphocytic Leukemia
    1.5 Global CD19-targeted CAR-T Cell Therapy Market Size & Forecast
    1.6 Global CD19-targeted CAR-T Cell Therapy Market Size and Forecast by Region
        1.6.1 Global CD19-targeted CAR-T Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global CD19-targeted CAR-T Cell Therapy Market Size by Region, (2019-2030)
        1.6.3 North America CD19-targeted CAR-T Cell Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe CD19-targeted CAR-T Cell Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific CD19-targeted CAR-T Cell Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America CD19-targeted CAR-T Cell Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Gilead (Yescarta&Tecartus)
        2.1.1 Gilead (Yescarta&Tecartus) Details
        2.1.2 Gilead (Yescarta&Tecartus) Major Business
        2.1.3 Gilead (Yescarta&Tecartus) CD19-targeted CAR-T Cell Therapy Product and Solutions
        2.1.4 Gilead (Yescarta&Tecartus) CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Gilead (Yescarta&Tecartus) Recent Developments and Future Plans
    2.2 Novartis (Kymriah)
        2.2.1 Novartis (Kymriah) Details
        2.2.2 Novartis (Kymriah) Major Business
        2.2.3 Novartis (Kymriah) CD19-targeted CAR-T Cell Therapy Product and Solutions
        2.2.4 Novartis (Kymriah) CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Novartis (Kymriah) Recent Developments and Future Plans
    2.3 Bristol-Myers Squibb (Breyanzi)
        2.3.1 Bristol-Myers Squibb (Breyanzi) Details
        2.3.2 Bristol-Myers Squibb (Breyanzi) Major Business
        2.3.3 Bristol-Myers Squibb (Breyanzi) CD19-targeted CAR-T Cell Therapy Product and Solutions
        2.3.4 Bristol-Myers Squibb (Breyanzi) CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Bristol-Myers Squibb (Breyanzi) Recent Developments and Future Plans
    2.4 FOSUNKite (Yescarta)
        2.4.1 FOSUNKite (Yescarta) Details
        2.4.2 FOSUNKite (Yescarta) Major Business
        2.4.3 FOSUNKite (Yescarta) CD19-targeted CAR-T Cell Therapy Product and Solutions
        2.4.4 FOSUNKite (Yescarta) CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 FOSUNKite (Yescarta) Recent Developments and Future Plans
    2.5 Shanghai Yaoming Juno (Carteyva)
        2.5.1 Shanghai Yaoming Juno (Carteyva) Details
        2.5.2 Shanghai Yaoming Juno (Carteyva) Major Business
        2.5.3 Shanghai Yaoming Juno (Carteyva) CD19-targeted CAR-T Cell Therapy Product and Solutions
        2.5.4 Shanghai Yaoming Juno (Carteyva) CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Shanghai Yaoming Juno (Carteyva) Recent Developments and Future Plans
    2.6 Juventas
        2.6.1 Juventas Details
        2.6.2 Juventas Major Business
        2.6.3 Juventas CD19-targeted CAR-T Cell Therapy Product and Solutions
        2.6.4 Juventas CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Juventas Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global CD19-targeted CAR-T Cell Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of CD19-targeted CAR-T Cell Therapy by Company Revenue
        3.2.2 Top 3 CD19-targeted CAR-T Cell Therapy Players Market Share in 2023
        3.2.3 Top 6 CD19-targeted CAR-T Cell Therapy Players Market Share in 2023
    3.3 CD19-targeted CAR-T Cell Therapy Market: Overall Company Footprint Analysis
        3.3.1 CD19-targeted CAR-T Cell Therapy Market: Region Footprint
        3.3.2 CD19-targeted CAR-T Cell Therapy Market: Company Product Type Footprint
        3.3.3 CD19-targeted CAR-T Cell Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global CD19-targeted CAR-T Cell Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global CD19-targeted CAR-T Cell Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global CD19-targeted CAR-T Cell Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America CD19-targeted CAR-T Cell Therapy Consumption Value by Type (2019-2030)
    6.2 North America CD19-targeted CAR-T Cell Therapy Market Size by Application (2019-2030)
    6.3 North America CD19-targeted CAR-T Cell Therapy Market Size by Country
        6.3.1 North America CD19-targeted CAR-T Cell Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe CD19-targeted CAR-T Cell Therapy Consumption Value by Type (2019-2030)
    7.2 Europe CD19-targeted CAR-T Cell Therapy Consumption Value by Application (2019-2030)
    7.3 Europe CD19-targeted CAR-T Cell Therapy Market Size by Country
        7.3.1 Europe CD19-targeted CAR-T Cell Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        7.3.3 France CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific CD19-targeted CAR-T Cell Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific CD19-targeted CAR-T Cell Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific CD19-targeted CAR-T Cell Therapy Market Size by Region
        8.3.1 Asia-Pacific CD19-targeted CAR-T Cell Therapy Consumption Value by Region (2019-2030)
        8.3.2 China CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        8.3.5 India CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America CD19-targeted CAR-T Cell Therapy Consumption Value by Type (2019-2030)
    9.2 South America CD19-targeted CAR-T Cell Therapy Consumption Value by Application (2019-2030)
    9.3 South America CD19-targeted CAR-T Cell Therapy Market Size by Country
        9.3.1 South America CD19-targeted CAR-T Cell Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa CD19-targeted CAR-T Cell Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa CD19-targeted CAR-T Cell Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa CD19-targeted CAR-T Cell Therapy Market Size by Country
        10.3.1 Middle East & Africa CD19-targeted CAR-T Cell Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE CD19-targeted CAR-T Cell Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 CD19-targeted CAR-T Cell Therapy Market Drivers
    11.2 CD19-targeted CAR-T Cell Therapy Market Restraints
    11.3 CD19-targeted CAR-T Cell Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 CD19-targeted CAR-T Cell Therapy Industry Chain
    12.2 CD19-targeted CAR-T Cell Therapy Upstream Analysis
    12.3 CD19-targeted CAR-T Cell Therapy Midstream Analysis
    12.4 CD19-targeted CAR-T Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global CD19-targeted CAR-T Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global CD19-targeted CAR-T Cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Global CD19-targeted CAR-T Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global CD19-targeted CAR-T Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. Gilead (Yescarta&Tecartus) Company Information, Head Office, and Major Competitors
 Table 6. Gilead (Yescarta&Tecartus) Major Business
 Table 7. Gilead (Yescarta&Tecartus) CD19-targeted CAR-T Cell Therapy Product and Solutions
 Table 8. Gilead (Yescarta&Tecartus) CD19-targeted CAR-T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. Gilead (Yescarta&Tecartus) Recent Developments and Future Plans
 Table 10. Novartis (Kymriah) Company Information, Head Office, and Major Competitors
 Table 11. Novartis (Kymriah) Major Business
 Table 12. Novartis (Kymriah) CD19-targeted CAR-T Cell Therapy Product and Solutions
 Table 13. Novartis (Kymriah) CD19-targeted CAR-T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. Novartis (Kymriah) Recent Developments and Future Plans
 Table 15. Bristol-Myers Squibb (Breyanzi) Company Information, Head Office, and Major Competitors
 Table 16. Bristol-Myers Squibb (Breyanzi) Major Business
 Table 17. Bristol-Myers Squibb (Breyanzi) CD19-targeted CAR-T Cell Therapy Product and Solutions
 Table 18. Bristol-Myers Squibb (Breyanzi) CD19-targeted CAR-T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 19. FOSUNKite (Yescarta) Company Information, Head Office, and Major Competitors
 Table 20. FOSUNKite (Yescarta) Major Business
 Table 21. FOSUNKite (Yescarta) CD19-targeted CAR-T Cell Therapy Product and Solutions
 Table 22. FOSUNKite (Yescarta) CD19-targeted CAR-T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 23. FOSUNKite (Yescarta) Recent Developments and Future Plans
 Table 24. Shanghai Yaoming Juno (Carteyva) Company Information, Head Office, and Major Competitors
 Table 25. Shanghai Yaoming Juno (Carteyva) Major Business
 Table 26. Shanghai Yaoming Juno (Carteyva) CD19-targeted CAR-T Cell Therapy Product and Solutions
 Table 27. Shanghai Yaoming Juno (Carteyva) CD19-targeted CAR-T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 28. Shanghai Yaoming Juno (Carteyva) Recent Developments and Future Plans
 Table 29. Juventas Company Information, Head Office, and Major Competitors
 Table 30. Juventas Major Business
 Table 31. Juventas CD19-targeted CAR-T Cell Therapy Product and Solutions
 Table 32. Juventas CD19-targeted CAR-T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 33. Juventas Recent Developments and Future Plans
 Table 34. Global CD19-targeted CAR-T Cell Therapy Revenue (USD Million) by Players (2019-2024)
 Table 35. Global CD19-targeted CAR-T Cell Therapy Revenue Share by Players (2019-2024)
 Table 36. Breakdown of CD19-targeted CAR-T Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 37. Market Position of Players in CD19-targeted CAR-T Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 38. Head Office of Key CD19-targeted CAR-T Cell Therapy Players
 Table 39. CD19-targeted CAR-T Cell Therapy Market: Company Product Type Footprint
 Table 40. CD19-targeted CAR-T Cell Therapy Market: Company Product Application Footprint
 Table 41. CD19-targeted CAR-T Cell Therapy New Market Entrants and Barriers to Market Entry
 Table 42. CD19-targeted CAR-T Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
 Table 43. Global CD19-targeted CAR-T Cell Therapy Consumption Value (USD Million) by Type (2019-2024)
 Table 44. Global CD19-targeted CAR-T Cell Therapy Consumption Value Share by Type (2019-2024)
 Table 45. Global CD19-targeted CAR-T Cell Therapy Consumption Value Forecast by Type (2025-2030)
 Table 46. Global CD19-targeted CAR-T Cell Therapy Consumption Value by Application (2019-2024)
 Table 47. Global CD19-targeted CAR-T Cell Therapy Consumption Value Forecast by Application (2025-2030)
 Table 48. North America CD19-targeted CAR-T Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 49. North America CD19-targeted CAR-T Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 50. North America CD19-targeted CAR-T Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 51. North America CD19-targeted CAR-T Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 52. North America CD19-targeted CAR-T Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 53. North America CD19-targeted CAR-T Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 54. Europe CD19-targeted CAR-T Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 55. Europe CD19-targeted CAR-T Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 56. Europe CD19-targeted CAR-T Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 57. Europe CD19-targeted CAR-T Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 58. Europe CD19-targeted CAR-T Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 59. Europe CD19-targeted CAR-T Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 60. Asia-Pacific CD19-targeted CAR-T Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 61. Asia-Pacific CD19-targeted CAR-T Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 62. Asia-Pacific CD19-targeted CAR-T Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 63. Asia-Pacific CD19-targeted CAR-T Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 64. Asia-Pacific CD19-targeted CAR-T Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 65. Asia-Pacific CD19-targeted CAR-T Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
 Table 66. South America CD19-targeted CAR-T Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 67. South America CD19-targeted CAR-T Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 68. South America CD19-targeted CAR-T Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 69. South America CD19-targeted CAR-T Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 70. South America CD19-targeted CAR-T Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 71. South America CD19-targeted CAR-T Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 72. Middle East & Africa CD19-targeted CAR-T Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 73. Middle East & Africa CD19-targeted CAR-T Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 74. Middle East & Africa CD19-targeted CAR-T Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 75. Middle East & Africa CD19-targeted CAR-T Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 76. Middle East & Africa CD19-targeted CAR-T Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 77. Middle East & Africa CD19-targeted CAR-T Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 78. Global Key Players of CD19-targeted CAR-T Cell Therapy Upstream (Raw Materials)
 Table 79. Global CD19-targeted CAR-T Cell Therapy Typical Customers


List of Figures
 Figure 1. CD19-targeted CAR-T Cell Therapy Picture
 Figure 2. Global CD19-targeted CAR-T Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Type in 2023
 Figure 4. Yescarta
 Figure 5. Kymriah
 Figure 6. Tecartus
 Figure 7. Others
 Figure 8. Global CD19-targeted CAR-T Cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 9. CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Application in 2023
 Figure 10. Lymphoma Picture
 Figure 11. Lymphocytic Leukemia Picture
 Figure 12. Global CD19-targeted CAR-T Cell Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 13. Global CD19-targeted CAR-T Cell Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 14. Global Market CD19-targeted CAR-T Cell Therapy Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 15. Global CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 16. Global CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Region in 2023
 Figure 17. North America CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 18. Europe CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 19. Asia-Pacific CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 20. South America CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 21. Middle East & Africa CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 22. Company Three Recent Developments and Future Plans
 Figure 23. Global CD19-targeted CAR-T Cell Therapy Revenue Share by Players in 2023
 Figure 24. CD19-targeted CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 25. Market Share of CD19-targeted CAR-T Cell Therapy by Player Revenue in 2023
 Figure 26. Top 3 CD19-targeted CAR-T Cell Therapy Players Market Share in 2023
 Figure 27. Top 6 CD19-targeted CAR-T Cell Therapy Players Market Share in 2023
 Figure 28. Global CD19-targeted CAR-T Cell Therapy Consumption Value Share by Type (2019-2024)
 Figure 29. Global CD19-targeted CAR-T Cell Therapy Market Share Forecast by Type (2025-2030)
 Figure 30. Global CD19-targeted CAR-T Cell Therapy Consumption Value Share by Application (2019-2024)
 Figure 31. Global CD19-targeted CAR-T Cell Therapy Market Share Forecast by Application (2025-2030)
 Figure 32. North America CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 33. North America CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 34. North America CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 35. United States CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 36. Canada CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 37. Mexico CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 38. Europe CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 39. Europe CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 40. Europe CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 41. Germany CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 42. France CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 43. United Kingdom CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 44. Russia CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 45. Italy CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 46. Asia-Pacific CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 47. Asia-Pacific CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 48. Asia-Pacific CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 49. China CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 50. Japan CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 51. South Korea CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 52. India CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 53. Southeast Asia CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 54. Australia CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 55. South America CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 56. South America CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 57. South America CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 58. Brazil CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 59. Argentina CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 60. Middle East & Africa CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 61. Middle East & Africa CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 62. Middle East & Africa CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 63. Turkey CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 64. Saudi Arabia CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 65. UAE CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 66. CD19-targeted CAR-T Cell Therapy Market Drivers
 Figure 67. CD19-targeted CAR-T Cell Therapy Market Restraints
 Figure 68. CD19-targeted CAR-T Cell Therapy Market Trends
 Figure 69. Porters Five Forces Analysis
 Figure 70. CD19-targeted CAR-T Cell Therapy Industrial Chain
 Figure 71. Methodology
 Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Gilead (Yescarta&Tecartus)
Novartis (Kymriah)
Bristol-Myers Squibb (Breyanzi)
FOSUNKite (Yescarta)
Shanghai Yaoming Juno (Carteyva)
Juventas

Related Reports

Global CD19-targeted CAR-T Cell Therapy Supply, Demand and Key Producers, 2024-2030

Global CD19-targeted CAR-T Cell Therapy Supply, Demand and Key Producers, 2024-2030

date 22 Nov 2024

date Pharma & Healthcare

The global CD19-targeted CAR-T Cell Therapy market size is expected to reach $ 7582 million by 2030, rising at a market growth of 15.3% CAGR during the forecast period (2024-2030).

Product Tags

CD19-targeted CAR-T Cell Therapy

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>